Dianthus Therapeutics, Inc. (DNTH)

Dianthus Therapeutics Revenue

Dianthus Therapeutics had revenue of $1.16M in the quarter ending March 31, 2025, with 33.07% growth. This brings the company's revenue in the last twelve months to $6.52M, up 102.36% year-over-year. In the year 2024, Dianthus Therapeutics had annual revenue of $6.24M with 120.63% growth.

• Revenue (ttm): $6.52M
• Revenue Growth: +102.36%
• P/S Ratio: 110.22
• Revenue / Employee: $83,641
• Employees: 78
• Market Cap: 645.13M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.24M	3.41M	120.63%
Dec 31, 2023	2.83M	-3.59M	-55.96%
Dec 31, 2022	6.42M	4.94M	334.76%
Dec 31, 2021	1.48M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.